Annals of Clinical Biochemistry > Volume 45, Number 1 > Pp. 6-10

This Article Figures Only Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Peaston, R. T Articles by Ball, S. Search for Related Content PubMed PubMed Citation Social Bookmarking                      What's this?

Personal View

Biochemical detection of phaeochromocytoma: why are we continuing to ignore the evidence?

Robert T Peaston ¹  and Stephen Ball ^2 3

¹ Department of Clinical Biochemistry, Freeman Hospital, Newcastle Hospitals NHS Trust, Newcastle NE7 7DN; ² School of Clinical Medical Sciences; ³ Department of Endocrinology, Newcastle University, Newcastle Hospitals NHS Trust, Newcastle NE1 4LP, UK

Corresponding author: Dr Robert T Peaston. Email: bob.peaston{at}nuth.nhs.uk

Phaeochromocytomas are rare tumours that require consideration among large numbers of patients with hypertension. If not diagnosed, the excessive secretion of catecholamines by these tumours can cause considerable morbidity and mortality. With a wide clinical variability in presentation, diagnosis can be difficult and invariably requires the biochemical confirmation of excessive catecholamine production by the tumour. At the First International Symposium on Phaeochromocytoma in October 2005, a panel of experts recommended that initial biochemical testing for phaeochromocytoma should include measurements of plasma and urinary metadrenalines. The accumulated evidence clearly indicates that measurement of fractionated metadrenalines in urine or plasma provides superior diagnostic sensitivity over plasma or urine measurements of catecholamines and metabolites. The low prevalence of phaeochromocytoma and paraganglioma (PGL) emphasizes the need to use biochemical tests of the highest sensitivity. To achieve this, it is recommended that the initial biochemical testing for phaeochromocytoma and secreting PGL should always include the measurements of metadrenalines in plasma or urine or both.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				M J Whiting Simultaneous measurement of urinary metanephrines and catecholamines by liquid chromatography with tandem mass spectrometric detection Ann Clin Biochem, March 1, 2009; 46(2): 129 - 136. [Abstract] [Full Text] [PDF]